Clinical Report: Diagnostic Accuracy and Learning Curve of mpMRI for Prostate Cancer Staging

Overview

This study evaluated the diagnostic accuracy of multiparametric MRI (mpMRI) for detecting locally advanced prostate cancer (pT3–4) in a real-life clinical setting and assessed the presence of a radiologic learning curve over time. Results showed moderate sensitivity and specificity for mpMRI in local staging, with no significant improvement in accuracy over the study period, suggesting limited impact of radiologist experience on staging performance.

Background

Prostate cancer is the most common malignancy in older men in Western countries, and accurate local staging is crucial for prognosis and treatment planning. Distinguishing organ-confined disease from locally advanced tumors guides surgical decisions such as nerve-sparing approaches and the need for extended lymph node dissection. Traditional clinical parameters and nomograms have limited staging accuracy, prompting increased use of mpMRI, which combines multiple imaging sequences to improve tumor detection and localization. However, mpMRI’s sensitivity for detecting extracapsular extension remains imperfect, and inter-observer variability may affect diagnostic performance.

Data Highlights

Key Findings

• mpMRI demonstrated moderate sensitivity and specificity for detecting locally advanced prostate cancer (pT3–4) prior to radical prostatectomy.
• Radiologists interpreting mpMRI were not blinded to clinical data, reflecting routine clinical practice.
• PI-RADS standardized reporting was increasingly adopted during the study period, rising from 0% in 2012 to over 65% in 2016.
• No statistically significant improvement in diagnostic accuracy was observed over time, indicating a limited radiologic learning curve for local staging.
• Diagnostic accuracy did not differ significantly between high-risk patients (Gleason ≥8 and/or PSA ≥20 ng/ml) and lower-risk groups.

Clinical Implications

mpMRI provides valuable but imperfect information for local staging of prostate cancer in routine clinical settings. Clinicians should interpret mpMRI findings in conjunction with clinical parameters and recognize that radiologist experience may not substantially improve staging accuracy. Continued use of standardized reporting systems like PI-RADS may help maintain consistency in interpretation.

Conclusion

mpMRI is a useful tool for assessing locally advanced prostate cancer but has moderate diagnostic accuracy with no clear evidence of improvement over time due to radiologist experience. Integration of mpMRI findings with clinical data remains essential for optimal treatment planning.

References

1. Western countries PCa incidence [1]
2. Prognostic importance of local staging [2]
3. Treatment planning and surgical considerations [3]
4. Risk of lymph node metastasis and ePLND [4,5]
5. Nerve-sparing surgery guidelines [6]
6. Radiotherapy planning based on local stage [7]
7. Limitations of routine diagnostics [9]
8. Nomogram accuracy [10,11]
9. mpMRI detection performance [12,13]
10. Inter-observer variability and learning curve [14-19]
11. PI-RADS v1 and v2 reporting standards [21,22]